Evidence map›Paper›PMID 26834043›Full record

ArticleBrain pathology (Zurich, Switzerland)2016

Primary Melanoma of the Leptomeninges with BAP1 Expression-Loss in the Setting of a Nevus of Ota: A Clinical, Morphological and Genetic Study of 2 Cases.

Gabrielle Goldman-Lévy, Valérie Rigau, Claire Bléchet, Guido Bens, Bertrand Muckensturm, Manuela Delage, François Labrousse, Véronique Haddad, Valéry Attignon, Daniel Pissaloux and 1 more

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gabrielle Goldman-LévyDepartment of Biopathology, University Hospital, 80 av Augustin Fliche, 34295 Montpellier Cedex 5, France.
Valérie RigauDepartment of Biopathology, University Hospital, 80 av Augustin Fliche, 34295 Montpellier Cedex 5, France.
Claire BléchetDepartment of Biopathology, La Source Hospital, 1 rue Porte Madeleine - 45000 Orléans, France.
Guido BensDepartment of Dermatology, La Source Hospital, 1 rue Porte Madeleine - 45000 Orléans, France.
Bertrand MuckensturmDepartment of Neurosurgery, La Source Hospital, 1 rue Porte Madeleine - 45000 Orléans, France.
Manuela DelageDepartment of Biopathology, Dupuytren University Hospital, 2 Avenue Martin Luther King, 87000, Limoges, France.
François LabrousseDepartment of Biopathology, Dupuytren University Hospital, 2 Avenue Martin Luther King, 87000, Limoges, France.
Véronique HaddadDepartment of Biopathology, Centre Léon Bérard, 28 rue Laennec, 69008, Lyon, France.
Valéry AttignonDepartment of Biopathology, Centre Léon Bérard, 28 rue Laennec, 69008, Lyon, France.
Daniel PissalouxDepartment of Biopathology, Centre Léon Bérard, 28 rue Laennec, 69008, Lyon, France.
Arnaud de la FouchardièreDepartment of Biopathology, Centre Léon Bérard, 28 rue Laennec, 69008, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedFemaleHumansMelanomaMeningeal NeoplasmsNevus of OtaTumor Suppressor ProteinsUbiquitin ThiolesteraseBAP1 protein, humanTumor Suppressor ProteinsUbiquitin Thiolesterase

Identifiers

PMID26834043
PMCPMC8029416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.